Osaka University · Faculty of Pharmaceutical Sciences / Graduate School of Pharmaceutical Sciences · 特任准教授

Research keywordsdrug discovery・protein-protein interaction inhibitors・machine learning screening・enteropeptidase inhibitors・antiobesity peptides・energy homeostasis・neuromedin U receptors・bombesin receptor subtype-3

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Applying deep learning to iterative screening of medium-sized molecules for protein-protein interaction-targeted drug discovery.2023 · Chemical communications (Cambridge, England) Vol. 59 No. 44 p. 6722-6725 2023年5月30日 研究論文（学術雑誌）
• Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning.2021 · Scientific reports Vol. 11 No. 1 p. 7420-7420 2021年4月1日 研究論文（学術雑誌）
• Discovery and characterization of a small-molecule enteropeptidase inhibitor, SCO-792.2019 · Pharmacology research & perspectives Vol. 7 No. 5 2019年10月 研究論文（学術雑誌）
• Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.2018 · British journal of pharmacology Vol. 175 No. 2 p. 359-373 2018年1月 研究論文（学術雑誌）

• Official profile